Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface
In human pathophysiology, the clash between microbial infection and host immunity
contributes to multiple diseases. Cystic fibrosis (CF) is a classical example of this …
contributes to multiple diseases. Cystic fibrosis (CF) is a classical example of this …
Immune Responses to Pseudomonas aeruginosa Biofilm Infections
Pseudomonas aeruginosa is a key pathogen of chronic infections in the lungs of cystic
fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these …
fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these …
Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
M Cafora, G Deflorian, F Forti, L Ferrari, G Binelli… - Scientific reports, 2019 - nature.com
Cystic fibrosis (CF) is a hereditary disease due to mutations in the CFTR gene and causes
mortality in humans mainly due to respiratory infections caused by Pseudomonas …
mortality in humans mainly due to respiratory infections caused by Pseudomonas …
Biofilms and host response–helpful or harmful
Biofilm infections are one of the modern medical world's greatest challenges. Probably, all
non‐obligate intracellular bacteria and fungi can establish biofilms. In addition, there are …
non‐obligate intracellular bacteria and fungi can establish biofilms. In addition, there are …
[HTML][HTML] Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis
Persistent neutrophil-dominated lung inflammation contributes to lung damage in cystic
fibrosis (CF). However, the mechanisms that drive persistent lung neutrophilia and tissue …
fibrosis (CF). However, the mechanisms that drive persistent lung neutrophilia and tissue …
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
Despite the addition of cystic fibrosis transmembrane conductance regulator (CFTR)
modulators to the cystic fibrosis (CF) treatment regimen, patients with CF continue to suffer …
modulators to the cystic fibrosis (CF) treatment regimen, patients with CF continue to suffer …
Trikafta rescues CFTR and lowers monocyte P2X7R-induced inflammasome activation in cystic fibrosis
C Gabillard-Lefort, M Casey, AMA Glasgow… - American journal of …, 2022 - atsjournals.org
Rationale: Cystic fibrosis (CF) is caused by mutations in the CFTR (CF transmembrane
conductance regulator) gene and is characterized by sustained inflammation. ATP triggers …
conductance regulator) gene and is characterized by sustained inflammation. ATP triggers …
Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
DS Aridgides, DL Mellinger, LL Gwilt, TH Hampton… - Scientific Reports, 2023 - nature.com
Macrophage dysfunction has been well-described in Cystic Fibrosis (CF) and may contribute
to bacterial persistence in the lung. Whether CF macrophage dysfunction is related directly …
to bacterial persistence in the lung. Whether CF macrophage dysfunction is related directly …
[PDF][PDF] The impact of highly effective modulator therapy on cystic fibrosis microbiology and inflammation
LJ Caverly, SA Riquelme, KB Hisert - Clinics in chest medicine, 2022 - Elsevier
Highly-effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator
therapy (HEMT) corrects the underlying molecular defect causing cystic fibrosis (CF) …
therapy (HEMT) corrects the underlying molecular defect causing cystic fibrosis (CF) …
Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
S Lara-Reyna, J Holbrook, HH Jarosz-Griffiths… - Cellular and Molecular …, 2020 - Springer
Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in
Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance …
Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance …